CD36 and breast carcinoma: We previously reported that tamoxifen inhibits macrophage CD36 expression to reduce macrophage/foam cell formation, the initial and critical step in the development of atherosclerosis10, which implies that inhibition of CD36 expression may be involved in tamoxifen-inhibited growth of breast cancer cells.